Genetic and Cystic Kidney Disorders

TitleGenetic and Cystic Kidney Disorders
Publication TypeJournal Article
Year of Publication2026
AuthorsWeimbs, T, Pastor-Soler, NM, Kovarik, JJ
JournalIntegrative Nephrology (M. Isreb, Editor)
VolumeText Book
Pagination407–431
ISBN Number978-3-032-24333-1
Abstract

Genetic kidney diseases represent a diverse spectrum of inherited disorders that

impact renal structure and function, often culminating in chronic kidney disease

(CKD) and end-stage kidney disease (ESKD). Among these, Autosomal-

Dominant Polycystic Kidney Disease (ADPKD) is the most prevalent, affecting

over 10 million individuals globally. While traditionally considered unmodi!-

able due to their genetic origins, recent advances suggest that many aspects of

disease progression across genetic kidney disorders, including ADPKD, may be

signi!cantly influenced by modi!able factors such as diet, metabolic health, and

environmental exposures.

This chapter explores the emerging framework of integrative nephrology in

the context of genetic kidney diseases, highlighting shared mechanisms that

drive disease progression such as renal inflammation, !brosis, metabolic dys-

regulation, and crystal-induced tubular injury. We present ADPKD as a paradigm

for integrative management, focusing on conservative, lifestyle-based interven-

tions such as therapeutic carbohydrate restriction, ketogenic metabolic therapy

(KMT), and the avoidance of dietary and environmental nephrotoxins. Clinical 

and preclinical studies suggest that these strategies can improve quality of life

and potentially slow or halt disease progression.

Emphasis is placed on patient-centered care, proactive education, and the

importance of addressing the psychosocial impact of receiving a genetic diagno-

sis. By reframing the management of genetic kidney disorders through the lens

of integrative nephrology, this chapter advocates for a hopeful, patient-centered,

actionable disease management approach that complements pharmacologic ther-

apy and empowers both clinicians and patients to effect a positive change on

kidney disease progression.

URLhttps://link.springer.com/chapter/10.1007/978-3-032-24334-8_14
DOI10.1007/978-3-032-24334-8_14